The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10mg/kg body weight per week to a patient.
申请公布号
EP2020438(A1)
申请公布日期
2009.02.04
申请号
EP20080164825
申请日期
1999.12.06
申请人
GENZYME CORPORATION
发明人
VAN BREE, JOHANNES, BRENARDUS, MATHIAS, MARIE;VENNEKER, EDNA, HENRIETTE, GERMAINE;MEEKER, DAVID, P.
